At Novum, integrity is everything from the initial study design through delivery of a submission ready report.
Since 1972, Novum has provided study design and protocol writing, clinical study conduct, data management, pharmacokinetic and statistical analyses, report writing, services and more to the pharmaceutical and associated industries for conducting Early Phase studies in multiple areas such as biologics, novel formulations and generic drugs. We have three Early Phase Clinical Pharmacology Units in the United States with a combined 647 beds and conduct approximately over 200 studies annually.
Early Phase Study List: FIH, SAD/MAD, PK/PD, Bioequivalence, Biocomparison, DDI, Drug-Device, Human Factor Studies. I/S, Adhesion, VCA
The Novum Early Phase Clinical Pharmacology Units have experience with: Respiratory Products (MDI, DPI, and Nasal Sprays), Transdermals, Oral Dosage Forms, Biologics, Locally Acting Products, and Natural Source Products.